Artificial Tears and the 20-20-20 Rule in Screen-Related Dry Eye Disease Therapeutic Principles and Clinical Application
Keywords:
Artificial Tears; 20-20-20 Rule; Dry Eye Disease; Digital Eye Strain; Ocular SurfaceAbstract
Background: Artificial tears are a principal first-line therapy for dry eye disease. They supplement the natural tear film, improve lubrication, and reduce irritation, burning, foreign-body sensation, and fluctuating vision. Formulations differ in viscosity, retention time, preservatives, lipid components, electrolytes, and osmolarity. Clinical response varies among patients. Screen-related symptoms are also influenced by prolonged near viewing, reduced or incomplete blinking, and visual fatigue. The 20-20-20 rule introduces regular visual breaks by encouraging users to look at a distant object.
Objective: To review the mechanisms of action, formulation differences, classification, clinical effects, safety considerations, and individualized selection of artificial tears. The review also examines the role of the 20-20-20 rule for reducing discomfort associated with prolonged screen exposure.
Conclusion: No single artificial tear formulation is suitable for every patient. Selection should reflect the predominant tear film deficiency, symptom pattern, required duration of relief, frequency of use, and tolerance of preservatives. More viscous preparations may remain longer on the ocular surface but may cause temporary visual blurring, whereas less viscous drops may require frequent application. Preservative-free preparations may be preferable for frequent use or sensitive ocular surfaces. Patients should receive instructions on correct use and should be reassessed when symptoms persist. The 20-20-20 rule interrupts continuous near work, relaxes sustained visual effort, and encourages complete blinking. It does not replace clinical evaluation or treatment for persistent dry eye disease. Combining individualized tear supplementation with structured visual breaks, conscious blinking, and appropriate screen-use habits may support symptom control, tear film stability, visual comfort, and ocular surface health.